On November 6, 2022, Foster Biologics announced the signing of a strategic cooperation agreement with Cytiva at the 5th China International Import Expo Enterprise, which will promote the standardization and scale up of local biologics CDMO services.
On November 9, 2022, the foundation stone of Foster Biologics’ biopharmaceutical industrialization project located at No. 589 Hongfeng Road, Linping Economic Development Zone, Hangzhou, China, was officially laid.
1st MFG Facility in Beijing (2,000L) obtained Manufacture License of Pharmaceutical Products issued by NMPA in 2021; additional 6,000L of MFG capacity to be commissioned by the end of 2022; Total MFG capacity 44,000L expected by Q3 2024
COPYRIGHT © FOSTERBIO. All Rights Reserved .京ICP备2021037222号-3
